eHealth Platforms Facilitate Prostate Cancer Shared Care: A Systematic Review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39273792/
eHealth will certainly play a central role in digital prostate cancer shared care, providing better health outcomes and care delivery. Future larger studies in this field should address the implementation...
Prostate cancer survivorship care has successfully transitioned to digital platforms, improving communication, symptom management, and engagement, while identifying ongoing needs for robust, patient-centered solutions.
[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!] - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39102055/
In view of a recent recommendation of the European Commission to conceptualize novel screening approaches for lung, gastric, and prostate cancer, Germany is also invoked to revise its prostate early...
Germany is revising its prostate cancer screening program, proposing organized and risk-adapted approaches based on new findings and the PROBASE trial, alongside European screening data.
Prostate Cancer Treatment (PDQ®): Health Professional Version - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/26389471/
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of prostate cancer. It is intended as a resource to inform and assist clinicians...
Comprehensive, peer-reviewed PDQ cancer information summary aids clinicians in prostate cancer treatment, reflecting independent literature reviews and regularly updated by the PDQ Adult Treatment Editorial Board.
Prostate cancer stem cells and their targeted therapies - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39175878/
Prostate cancer (PCa) is the most common malignancy among men worldwide. Through androgen receptor signaling inhibitor (ARSI) treatment, patients eventually succumb to castration-resistant prostate cancer (CRPC). For this, the prostate...
Targeting Androgen Receptor Alterations in Metastatic Prostate Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39107195/
There have been significant advances in our understanding of the biology of metastatic prostate cancer (mPCa) and its response to therapy. Androgen receptor (AR) alterations, including mutations, amplifications, splice variants,...
Advances in metastatic prostate cancer treatment target androgen receptor alterations, with promising results from new therapies and ongoing trials evaluating efficacy based on AR mutation status.